Aditi Technologies, Microsoft BioIT Alliance sign agreement on Bioinformatics program

Aditi Technologies, a leading provider of software product and application development services, today announced its strategic partnership with Microsoft BioIT Alliance to extend its services focus into Bioinformatics. This will allow players in this rapidly evolving industry to leverage Aditi's superlative product development capability, domain knowledge and best practices know-how.

This alliance provides Aditi access to the global BioIT ecosystem and helps in increasing its footprint in Bioinformatics space. It also lets Aditi showcase its technical competence and domain experience. Aditi's thumping success with critical Bioinformatics program in Microsoft Research (http://research.microsoft.com/)was a precursor to this alliance.

"We welcome Aditi Technologies into the BioIT Alliance and are pleased to see the company investing in Bio informatics space," said Les Jordan, Director Bio IT Alliance. "Aditi's membership in the alliance brings new intellectual capital to our collaborative effort and continues to build on the momentum that the alliance has established in this space."

"BioIT is exciting," said Pankaj Jindal, President, Aditi Technologies. "We believe that this partnership offers a winning proposition to all the stakeholders. Aditi's best-of-breed product development capability combined with rich domain expertise will provide our clients a unique and unbeatable value proposition. It would offer both Aditi and BioIT Alliance an opportunity to grow faster and serve their partners better by leveraging each other's strengths."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists reveal how miRNAs shape cancer and offer new paths for treatment